Jaguar Health Inc (JAGX)

09:50 AM

Jaguar Health to present results from OnTarget study in breast cancer patients - Yahoo Finance

09:50 AM

Apr 15, 2025

Jaguar Health to discuss breast cancer treatment with FDA By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Jaguar Health (JAGX) Advances OnTarget Study with Key Presentati - GuruFocus

Apr 15, 2025

Apr 15, 2025

Jaguar Health Announces Significant Results in Breast Cancer Pat - GuruFocus

Apr 15, 2025

Apr 15, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 15, 2025

Apr 15, 2025

Game-Changing Results: New Cancer Drug Shows Remarkable Success in Breast Cancer Patients - Stock Titan

Apr 15, 2025

Apr 13, 2025

Jaguar Health, Inc. Announces 1-for-70 Reverse Stock Split - ACCESS Newswire

Apr 13, 2025

Apr 08, 2025

Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2024 Earnings Call Transcript - MSN

Apr 08, 2025

Apr 08, 2025

Jaguar Health's Wholly Owned Subsidiary, Napo Pharmaceuticals, Inc., Commits to Support Study Evaluating the Effect of Crofelemer on Patients With Chronic Idiopathic Diarrhea - ACCESS Newswire

Apr 08, 2025

Apr 08, 2025

Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting - GuruFocus

Apr 08, 2025

Apr 08, 2025

Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product - markets.businessinsider.com

Apr 08, 2025

Apr 08, 2025

Revolutionary Pain Relief: New FDA-Approved Treatment Transforms Cancer Care Experience - Stock Titan

Apr 08, 2025

Apr 06, 2025

Jaguar Health's Italian Subsidiary Napo EU Appoints Annabella Amatulli Chief Regulatory Officer - ACCESS Newswire

Apr 06, 2025

Apr 05, 2025

Jaguar Health (NASDAQ:JAGX) Shares Cross Below Two Hundred Day Moving Average – What’s Next? - Defense World

Apr 05, 2025

Apr 04, 2025

Jaguar Animal Health Secures $3.448M in Private Placement - TipRanks

Apr 04, 2025

Apr 04, 2025

Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

Jaguar Health Expands Workforce: New Stock Grants Signal Growth Strategy - Stock Titan

Apr 04, 2025

Apr 04, 2025

Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4) - ACCESS Newswire

Apr 04, 2025

Apr 03, 2025

Jaguar Health outlines key Q2 2025 catalysts for crofelemer programs - MSN

Apr 03, 2025

Apr 03, 2025

Jaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product - ACCESS Newswire

Apr 03, 2025

Apr 02, 2025

Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

Jaguar Health completes $3.4 million private placement By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Jaguar Health completes $3.4 million private placement - Investing.com India

Apr 01, 2025

Apr 01, 2025

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire

Apr 01, 2025

Apr 01, 2025

Jaguar Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025

Apr 01, 2025

Jaguar Health Advances Plant-Based Pharmaceuticals - TipRanks

Apr 01, 2025

Mar 31, 2025

Jaguar Health’s Earnings Call: Growth Amid Challenges - TipRanks

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Jaguar Health sees revenue growth in Q4 2024 - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

JAGX stock plunges to 52-week low, touches $4.9 amid steep decline By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

JAGX stock plunges to 52-week low, touches $4.9 amid steep decline - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Jaguar Health sees revenue growth in Q4 2024 By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023 - ACCESS Newswire

Mar 31, 2025

Mar 31, 2025

Jaguar Health, Inc. SEC 10-K Report - TradingView

Mar 31, 2025

Mar 28, 2025

StockNews.com Begins Coverage on Jaguar Health (NASDAQ:JAGX) - Defense World

Mar 28, 2025

Mar 28, 2025

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey - Weatherford Democrat

Mar 28, 2025

Mar 27, 2025

Jaguar Health at Emerging Growth Virtual Conference: Strategic Catalysts Ahead - Investing.com

Mar 27, 2025

Mar 27, 2025

Jaguar Health CEO, board members and investors invest in $3.448M bridge financing - MSN

Mar 27, 2025

Mar 27, 2025

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study - ACCESS Newswire

Mar 27, 2025

Mar 27, 2025

Mytesi Shows Promising Results in Breast Cancer: FDA to Review Game-Changing Phase 3 Data - Stock Titan

Mar 27, 2025

Mar 26, 2025

Jaguar Health secures $3.448 million in convertible notes By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Sector Update: Health Care - MarketScreener

Mar 26, 2025

Mar 26, 2025

Jaguar Health secures $3.448 million in convertible notes - Investing.com

Mar 26, 2025

Mar 26, 2025

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts - Corsicana Daily Sun

Mar 26, 2025

Mar 26, 2025

Jaguar Health Executives Invest in $3.5 Million Bridge Financing; Shares Fall - MarketScreener

Mar 26, 2025